LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - Mersana Therapeutics (NASDAQ: MRSN)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ MRSN Mersana Therapeutics
Bala Mohan / officer: SVP, Chief Development Officer
10/27/2025
Sell
$9.90
77
$762
2,922